The Clinical Presentation and Diagnosis of Vogt-Koyanagi-Harada Syndrome
Bhupinder Johala, Herman Johala, Andrew Lukaris
Vogt–Koyanagi–Harada syndrome (VKH) is a rare inflammatory disorder diagnosed clinically that presents as panuveitis with serous retinal detachments among other systemic symptoms.1 Treatment options for this disease vary, but pharmacotherapy with systemic corticosteroids is the mainstay. Ruling out infectious causes prior to initiation of corticosteroids is vital as immunosuppression may worsen disease of an infectious etiology. Herein, we describe an otherwise healthy 34–year–old Métis woman with a three–week history of bilateral uveitis presenting with new onset of tinnitus and skin pigment changes started on high–dose IV corticosteroids with clinical improvement of symptoms.
Johala B, Johala H, Lukaris A. The Clinical Presentation and Diagnosis of Vogt-Koyanagi-Harada Syndrome. UBCMJ. 2015; 6(2):20-22.